Literature DB >> 26118690

Microenvironment and HIV-related lymphomagenesis.

Liron Pantanowitz1, Antonino Carbone2, Riccardo Dolcetti3.   

Abstract

Patients with HIV infection are at increased risk of developing non-Hodgkin lymphoma and Hodgkin lymphoma. While the pathogenesis of these lymphomas is incompletely understood, evidence indicates that immune deregulation, genetic alterations and cytokine production play an important role in HIV lymphomagenesis. The lymphoma microenvironment in this heterogeneous group of lymphomas plays an equally critical role in their development, growth and progression. Important components of the microenvironment in HIV-related lymphomas include EBV and/or HHV-8 coinfection, reactive inflammatory cells, tumor microvasculature, and soluble factors. This paper provides a brief overview of HIV-related lymphomas and focuses on their lymphomagenesis and microenvironment.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AIDS; EBV; HHV8; HIV; Lymphoma; Microenvironment

Mesh:

Year:  2015        PMID: 26118690     DOI: 10.1016/j.semcancer.2015.06.002

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  7 in total

1.  EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity.

Authors:  M K Gandhi; T Hoang; S C Law; S Brosda; K O'Rourke; J W D Tobin; F Vari; V Murigneux; L Fink; J Gunawardana; C Gould; H Oey; K Bednarska; S Delecluse; R U Trappe; L Merida de Long; M B Sabdia; G Bhagat; G Hapgood; E Blyth; L Clancy; J Wight; E Hawkes; L M Rimsza; A Maguire; K Bojarczuk; B Chapuy; C Keane
Journal:  Blood       Date:  2021-03-18       Impact factor: 22.113

Review 2.  A lymphomagenic role for HIV beyond immune suppression?

Authors:  Riccardo Dolcetti; Annunziata Gloghini; Arnaldo Caruso; Antonino Carbone
Journal:  Blood       Date:  2016-01-14       Impact factor: 22.113

3.  In the South African setting, HIV-associated Burkitt lymphoma is associated with frequent leukaemic presentation, complex cytogenetic karyotypes, and adverse clinical outcomes.

Authors:  Jessica Opie; Katherine Antel; Ania Koller; Nicolas Novitzky
Journal:  Ann Hematol       Date:  2020-01-18       Impact factor: 3.673

4.  Identifying transcriptional profiles and evaluating prognostic biomarkers of HIV-associated diffuse large B-cell lymphoma from Malawi.

Authors:  Yuri Fedoriw; Sara Selitsky; Nathan D Montgomery; Sviatoslav M Kendall; Kristy L Richards; Wei Du; Tamiwe Tomoka; Maurice Mulenga; Joel S Parker; Sandeep S Dave; Satish Gopal
Journal:  Mod Pathol       Date:  2020-02-20       Impact factor: 7.842

5.  Survival and predictors of death in people with HIV-associated lymphoma compared to those with a diagnosis of lymphoma in general population.

Authors:  Antonella Cingolani; Alessandro Cozzi Lepri; Luciana Teofili; Laura Galli; Valentina Mazzotta; Gian Maria Baldin; Stefan Hohaus; Alessandra Bandera; Lucia Alba; Nadia Galizzi; Antonella Castagna; Antonella D'arminio Monforte; Andrea Antinori
Journal:  PLoS One       Date:  2017-10-31       Impact factor: 3.240

6.  Risk, Diagnostic and Predictor Factors for Classical Hodgkin Lymphoma in HIV-1-Infected Individuals: Role of Plasma Exosome-Derived miR-20a and miR-21.

Authors:  Francisco J Hernández-Walias; Esther Vázquez; Yolanda Pacheco; José M Rodríguez-Fernández; María J Pérez-Elías; Fernando Dronda; José L Casado; Ana Moreno; José M Hermida; Carmen Quereda; Asunción Hernando; Francisco Tejerina-Picado; Víctor Asensi; María J Galindo; Manuel Leal; Santiago Moreno; Alejandro Vallejo
Journal:  J Clin Med       Date:  2020-03-11       Impact factor: 4.241

7.  EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mice.

Authors:  Chunrong Li; James C Romero-Masters; Shane Huebner; Makoto Ohashi; Mitchell Hayes; Jillian A Bristol; Scott E Nelson; Mark R Eichelberg; Nicholas Van Sciver; Erik A Ranheim; Rona S Scott; Eric C Johannsen; Shannon C Kenney
Journal:  PLoS Pathog       Date:  2020-06-15       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.